Blog

Blog | Market insights

Sharesight20 top 20 trades on ASX – August 2020

by Stephanie Stefanovic, Content Manager, Sharesight | Aug 25th 2020

Disclaimer: The below article is for informational purposes only and does not constitute a product recommendation, or taxation or financial advice and should not be relied upon as such. Always check with your financial adviser or accountant to obtain the correct advice for your situation.

Welcome to the August 2020 edition of the Sharesight20ASX monthly trading snapshot, where we look at the top 20 trades Sharesight users made on the ASX during the month.

Sharesight20 top 20 ASX trades August 2020

Top20 ASX monthly Aug2020

In August’s Sharesight20ASX snapshot, Mesoblast (ASX: MSB) dominates the list of buy and sell trades, as investors cash in on the hype around the company’s ongoing clinical trials. Interest in the buy-now-pay-later (BNPL) sector also continues from last month, as main players Afterpay (ASX: APT) and Zip Co (ASX: Z1P) make big moves towards international expansion.

Let’s look at the news behind some of the key stocks in this month’s snapshot:

Mesoblast Ltd (ASX: MSB)

Share prices soar as Mesoblast progresses on Covid-19 vaccine and stem cell treatment
ASX propped up by Mesoblast share price gains
Business booming for Mesoblast during Covid-19
Mesoblast share price drops after FDA reports released on stem cell therapy

Commonwealth Bank (ASX: CBA)

CBA dividend payout better than expected despite profit loss
CBA served with class action; accused of insurance rort
Big pay rise for CBA executives despite falling FY20 profits
CBA temporarily closes 114 branches Australia-wide due to Covid-19 downturn

Kogan.com Ltd (ASX: KGN)

Kogan profits surge 56% as shoppers turn online
Founders sell $163 million worth of shares
Kogan joins JB Hi-Fi as best-faring Australian retailers amid Covid-19 downturn

Westpac Banking Corp (ASX: WBC)

More Westpac money laundering and counter-terrorism breaches discovered

ResMed Inc (ASX: RMD)

ResMed optimistic on future post-Covid-19
ResMed posts strong Q4 results
ResMed joins list of Covid-boosted businesses

National Australia Bank (ASX: NAB)

Q3 results better than expected for NAB
Thousands of NAB jobs on the line amid company restructure
NAB slashes branch hours in regional towns

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

Track all your investments in one place, including stocks, mutual/managed funds, property, and even cryptocurrency
Get the true picture of your investment performance, including the impact of brokerage fees, dividends, and capital gains with Sharesight’s annualised performance calculation methodology
Run powerful reports built for investors, including Performance, Portfolio Diversity, Contribution Analysis and Future Income (upcoming dividends)
Run tax reports including Taxable Income (dividends/distributions), Capital Gains Tax (Australia and Canada), Traders Tax (Capital Gains for traders in NZ) and FIF foreign investment fund income reports (NZ)